TrialBrain : a journal of neurology2021

Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease.

Dawn C Matthews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.